USA - NASDAQ:SRGA - US86882C2044 - Common Stock
The current stock price of SRGA is 0.1829 USD. In the past month the price decreased by -75.93%. In the past year, price decreased by -94.35%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.85 | 14.27B | ||
| SOLV | SOLVENTUM CORP | 12.72 | 13.10B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14 | 9.81B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.99 | 5.07B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.78 | 3.56B | ||
| HAE | HAEMONETICS CORP/MASS | 15.28 | 3.53B | ||
| ICUI | ICU MEDICAL INC | 17.02 | 3.35B | ||
| XRAY | DENTSPLY SIRONA INC | 6.66 | 2.10B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.52 | 1.76B | ||
| NEOG | NEOGEN CORP | 21.13 | 1.38B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.30B | ||
| EMBC | EMBECTA CORP | 4.9 | 837.58M |
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
SURGALIGN HOLDINGS INC
520 Lake Cook Rd Ste 315
Deerfield ILLINOIS 60015 US
CEO: Terry M. Rich
Employees: 217
Phone: 18773436832.0
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
The current stock price of SRGA is 0.1829 USD. The price decreased by -32.98% in the last trading session.
SRGA does not pay a dividend.
SRGA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.
SURGALIGN HOLDINGS INC (SRGA) currently has 217 employees.
SURGALIGN HOLDINGS INC (SRGA) has a market capitalization of 1.68M USD. This makes SRGA a Nano Cap stock.
ChartMill assigns a fundamental rating of 1 / 10 to SRGA. SRGA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months SRGA reported a non-GAAP Earnings per Share(EPS) of -5.81. The EPS increased by 50.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.
For the next year, analysts expect an EPS growth of -58.25% and a revenue growth -37.13% for SRGA